{
 "ok": true,
 "cik": "1662774",
 "ticker": "QNCX",
 "name": "Quince Therapeutics, Inc.",
 "filings": [
  {
   "form": "8-K",
   "filed": "2026-09-14",
   "items": [
    "2.01 Completion of Acquisition or Disposition of Assets",
    "5.02 Departure or Election of Directors; Appointment of Officers",
    "9.01 Financial Statements and Exhibits"
   ],
   "url": "https://www.sec.gov/Archives/edgar/data/1662774/000119312526390652/0001193125-26-390652-index.htm"
  },
  {
   "form": "8-K",
   "filed": "2026-09-04",
   "items": [
    "3.01 Notice of Delisting or Failure to Satisfy a Listing Rule"
   ],
   "url": "https://www.sec.gov/Archives/edgar/data/1662774/000119312526382838/0001193125-26-382838-index.htm"
  },
  {
   "form": "8-K",
   "filed": "2026-08-27",
   "items": [
    "5.02 Departure or Election of Directors; Appointment of Officers"
   ],
   "url": "https://www.sec.gov/Archives/edgar/data/1662774/000119312526371389/0001193125-26-371389-index.htm"
  },
  {
   "form": "DEF 14A",
   "filed": "2026-08-25",
   "items": [],
   "url": "https://www.sec.gov/Archives/edgar/data/1662774/000119312526364220/0001193125-26-364220-index.htm"
  },
  {
   "form": "8-K",
   "filed": "2026-08-17",
   "items": [
    "8.01 Other Events",
    "9.01 Financial Statements and Exhibits"
   ],
   "url": "https://www.sec.gov/Archives/edgar/data/1662774/000119312526353141/0001193125-26-353141-index.htm"
  },
  {
   "form": "10-Q",
   "filed": "2026-08-14",
   "items": [],
   "url": "https://www.sec.gov/Archives/edgar/data/1662774/000119312526352201/0001193125-26-352201-index.htm"
  }
 ],
 "events12m": 21,
 "sources": {
  "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001662774.json",
  "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1662774"
 },
 "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.",
 "notAdvice": "Reporting, not investment advice. No price targets, no buy or sell views.",
 "edgar": "🫧 Edgar looked up Quince Therapeutics, Inc. ($QNCX). Last filing: 8-K (2.01 Completion of Acquisition or Disposition of Assets), 2026-09-14. 21 event filings (8-K) in the past twelve months.",
 "auditor": {
  "changes": [],
  "nonReliance": [],
  "restatedSince": null
 },
 "edgarette": "🔖 The filings carry no annual revenue line Edgarette can read (common for banks and insurers, which report income differently). Nothing weighed, nothing guessed."
}